Charles Schwab’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $746M | Buy |
8,607,355
+296,360
| +4% | +$28.4M | 0.11% | 145 |
|
|
2025
Q4 | $798M | Buy |
8,310,995
+135,204
| +2% | +$13.1M | 0.12% | 136 |
|
|
2025
Q3 | $779M | Buy |
8,175,791
+15,525
| +0.2% | +$1.43M | 0.12% | 139 |
|
|
2025
Q2 | $711M | Buy |
8,160,266
+118,314
| +1% | +$10M | 0.12% | 143 |
|
|
2025
Q1 | $723M | Buy |
8,041,952
+39,901
| +0.5% | +$3.57M | 0.14% | 134 |
|
|
2024
Q4 | $639M | Buy |
8,002,051
+134,647
| +2% | +$11.7M | 0.12% | 143 |
|
|
2024
Q3 | $708M | Sell |
7,867,404
-188,831
| -2% | -$15.9M | 0.14% | 129 |
|
|
2024
Q2 | $634M | Sell |
8,056,235
-3,161,650
| -28% | -$259M | 0.12% | 144 |
|
|
2024
Q1 | $954M | Buy |
11,217,885
+128,485
| +1% | +$11M | 0.22% | 77 |
|
|
2023
Q4 | $893M | Buy |
11,089,400
+101,111
| +0.9% | +$7.71M | 0.23% | 77 |
|
|
2023
Q3 | $844M | Buy |
10,988,289
+79,660
| +0.7% | +$6.67M | 0.24% | 72 |
|
|
2023
Q2 | $943M | Buy |
10,908,629
+2,271
| +0% | +$196K | 0.27% | 67 |
|
|
2023
Q1 | $864M | Buy |
10,906,358
+1,590,562
| +17% | +$130M | 0.26% | 72 |
|
|
2022
Q4 | $715M | Buy |
9,315,796
+255,281
| +3% | +$20.7M | 0.23% | 84 |
|
|
2022
Q3 | $732M | Buy |
9,060,515
+1,222,337
| +16% | +$110M | 0.26% | 68 |
|
|
2022
Q2 | $703M | Buy |
7,838,178
+1,036,982
| +15% | +$105M | 0.24% | 79 |
|
|
2022
Q1 | $755M | Buy |
6,801,196
+128,661
| +2% | +$13.6M | 0.23% | 81 |
|
|
2021
Q4 | $690M | Buy |
6,672,535
+229,656
| +4% | +$26.6M | 0.2% | 87 |
|
|
2021
Q3 | $808M | Buy |
6,442,879
+78,753
| +1% | +$10.2M | 0.26% | 72 |
|
|
2021
Q2 | $790M | Buy |
6,364,126
+89,983
| +1% | +$11.3M | 0.26% | 69 |
|
|
2021
Q1 | $741M | Buy |
6,274,143
+93,783
| +2% | +$11M | 0.27% | 68 |
|
|
2020
Q4 | $724M | Sell |
6,180,360
-66,698
| -1% | -$7.34M | 0.29% | 65 |
|
|
2020
Q3 | $649M | Sell |
6,247,058
-354,642
| -5% | -$35.6M | 0.3% | 65 |
|
|
2020
Q2 | $605M | Sell |
6,601,700
-218,291
| -3% | -$20.9M | 0.3% | 65 |
|
|
2020
Q1 | $615M | Buy |
6,819,991
+221,909
| +3% | +$23.6M | 0.36% | 51 |
|
|
2019
Q4 | $749M | Buy |
6,598,082
+81,561
| +1% | +$8.95M | 0.4% | 41 |
|
|
2019
Q3 | $708M | Buy |
6,516,521
+116,060
| +2% | +$12.1M | 0.42% | 39 |
|
|
2019
Q2 | $623M | Buy |
6,400,461
+379,970
| +6% | +$34.7M | 0.38% | 43 |
|
|
2019
Q1 | $548M | Buy |
6,020,491
+318,881
| +6% | +$28.5M | 0.35% | 47 |
|
|
2018
Q4 | $519M | Buy |
5,701,610
+208,780
| +4% | +$19.5M | 0.4% | 43 |
|
|
2018
Q3 | $540M | Buy |
5,492,830
+128,313
| +2% | +$11.9M | 0.36% | 47 |
|
|
2018
Q2 | $459M | Buy |
5,364,517
+114,365
| +2% | +$9.55M | 0.33% | 51 |
|
|
2018
Q1 | $421M | Buy |
5,250,152
+220,808
| +4% | +$18.2M | 0.33% | 52 |
|
|
2017
Q4 | $406M | Buy |
5,029,344
+227,449
| +5% | +$18.2M | 0.32% | 47 |
|
|
2017
Q3 | $373M | Buy |
4,801,895
+208,349
| +5% | +$17.3M | 0.33% | 49 |
|
|
2017
Q2 | $408M | Buy |
4,593,546
+222,980
| +5% | +$18.8M | 0.38% | 40 |
|
|
2017
Q1 | $352M | Buy |
4,370,566
+142,729
| +3% | +$11.1M | 0.35% | 44 |
|
|
2016
Q4 | $301M | Buy |
4,227,837
+9,683
| +0.2% | +$761K | 0.33% | 47 |
|
|
2016
Q3 | $364M | Buy |
4,218,154
+27,137
| +0.6% | +$2.36M | 0.43% | 39 |
|
|
2016
Q2 | $364M | Buy |
4,191,017
+91,479
| +2% | +$7.4M | 0.45% | 40 |
|
|
2016
Q1 | $307M | Buy |
4,099,538
+302,514
| +8% | +$22.8M | 0.4% | 42 |
|
|
2015
Q4 | $292M | Buy |
3,797,024
+77,866
| +2% | +$5.86M | 0.39% | 47 |
|
|
2015
Q3 | $249M | Sell |
3,719,158
-31,463
| -0.8% | -$2.32M | 0.37% | 50 |
|
|
2015
Q2 | $278M | Buy |
3,750,621
+31,299
| +0.8% | +$2.39M | 0.38% | 51 |
|
|
2015
Q1 | $290M | Buy |
3,719,322
+1,307,068
| +54% | +$99.1M | 0.41% | 48 |
|
|
2014
Q4 | $174M | Buy |
2,412,254
+92,731
| +4% | +$6.44M | 0.26% | 73 |
|
|
2014
Q3 | $144M | Sell |
2,319,523
-2,062,128
| -47% | -$131M | 0.24% | 81 |
|
|
2014
Q2 | $279M | Sell |
4,381,651
-85,043
| -2% | -$5.17M | 0.47% | 35 |
|
|
2014
Q1 | $275M | Buy |
4,466,694
+177,381
| +4% | +$10.3M | 0.49% | 35 |
|
|
2013
Q4 | $246M | Sell |
4,289,313
-90,154
| -2% | -$5.11M | 0.47% | 39 |
|
|
2013
Q3 | $234M | Buy |
4,379,467
+241,577
| +6% | +$13M | 0.48% | 34 |
|
|
2013
Q2 | $215M | Buy |
+4,137,890
| New | +$205M | 0.48% | 33 |
|
Other funds holding MDT
VCM
VPM
Charles Schwab's MDT Position: Q1 2026 in Review
Charles Schwab increased its Medtronic (MDT) stake by 3.6% in Q1 2026, buying an estimated $28.4M and bringing the position to 8,607,355 shares worth $746M. The position accounts for 0.11% of the portfolio, ranked #145.
Charles Schwab first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $954M in Q1 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Charles Schwab held 8,607,355 shares of Medtronic worth $746M as of Q1 2026.
- Charles Schwab bought 296,360 Medtronic shares in Q1 2026, an estimated $28.4M.
- Medtronic made up 0.11% of Charles Schwab's portfolio in Q1 2026, its #145 holding.
- Charles Schwab first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
- Charles Schwab's Medtronic position peaked at $954M in Q1 2024.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.